Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-333771
Filing Date
2021-11-18
Accepted
2021-11-18 16:01:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4634
  Complete submission text file 0001193125-21-333771.txt   5664
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)